Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Walther J A A van den Broek"'
Autor:
Tayma Handal, Sarah Juster, Manar Abu Diab, Shira Yanovsky-Dagan, Fouad Zahdeh, Uria Aviel, Roni Sarel-Gallily, Shir Michael, Ester Bnaya, Shulamit Sebban, Yosef Buganim, Yotam Drier, Vincent Mouly, Stefan Kubicek, Walther J. A. A. van den Broek, Derick G. Wansink, Silvina Epsztejn-Litman, Rachel Eiges
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Epigenetic defects caused by hereditary or de novo mutations are implicated in various human diseases. It remains uncertain whether correcting the underlying mutation can reverse these defects in patient cells. Here we show by the analysis o
Externí odkaz:
https://doaj.org/article/f2f26f7be8be43019350e3bc09541979
Autor:
Anchel González-Barriga, Julia Kranzen, Huib J E Croes, Suzanne Bijl, Walther J A A van den Broek, Ingeborg D G van Kessel, Baziel G M van Engelen, Judith C T van Deutekom, Bé Wieringa, Susan A M Mulders, Derick G Wansink
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121556 (2015)
Myotonic Dystrophy type 1 (DM1) is a multisystemic disease caused by toxic RNA from a DMPK gene carrying an expanded (CTG•CAG)n repeat. Promising strategies for treatment of DM1 patients are currently being tested. These include antisense oligonucl
Externí odkaz:
https://doaj.org/article/e315422256e242feba27e3e2c97a4a55
Autor:
Derick G. Wansink, Marieke Willemse, Ingeborg D.G. van Kessel, Walther J. A. A. van den Broek, Laurène M. André, Geneviève Gourdon, Bé Wieringa, Ellen L. van Agtmaal, Denis Furling, Vincent Mouly, Darren G. Monckton, Sarah A. Cumming
Publikováno v:
Molecular Therapy
Molecular Therapy, Cell Press, 2017, 25 (1), pp.24-43. ⟨10.1016/j.ymthe.2016.10.014⟩
Molecular Therapy, 25, 1, pp. 24-43
Molecular Therapy, 25, 24-43
Molecular Therapy, Nature Publishing Group, 2017, 25 (1), pp.24-43. 〈10.1016/j.ymthe.2016.10.014〉
Molecular Therapy, 2017, 25 (1), pp.24-43. ⟨10.1016/j.ymthe.2016.10.014⟩
Molecular Therapy, Cell Press, 2017, 25 (1), pp.24-43. ⟨10.1016/j.ymthe.2016.10.014⟩
Molecular Therapy, 25, 1, pp. 24-43
Molecular Therapy, 25, 24-43
Molecular Therapy, Nature Publishing Group, 2017, 25 (1), pp.24-43. 〈10.1016/j.ymthe.2016.10.014〉
Molecular Therapy, 2017, 25 (1), pp.24-43. ⟨10.1016/j.ymthe.2016.10.014⟩
Myotonic dystrophy type 1 (DM1) is caused by (CTG⋅CAG)n-repeat expansion within the DMPK gene and thought to be mediated by a toxic RNA gain of function. Current attempts to develop therapy for this disease mainly aim at destroying or blocking abno
Autor:
Anke E. E. G. Gudde, Bé Wieringa, Derick G. Wansink, Walther J. A. A. van den Broek, Anchel González-Barriga
Publikováno v:
Human Molecular Genetics, 25, 8, pp. 1648-62
Human Molecular Genetics, 25, 1648-62
Human Molecular Genetics
Human Molecular Genetics, 25, 1648-62
Human Molecular Genetics
Contains fulltext : 172255.pdf (Publisher’s version ) (Open Access) Muscular manifestation of myotonic dystrophy type 1 (DM1), a common inheritable degenerative multisystem disorder, is mainly caused by expression of RNA from a (CTG.CAG)n-expanded
Autor:
Geneviève Gourdon, Sjef J. de Kimpe, Gerard Johannes Platenburg, Derick G. Wansink, Charles A. Thornton, Bé Wieringa, Walther J. A. A. van den Broek, Susan A. M. Mulders, Thurman M. Wheeler, Denis Furling, H.J.E. Croes, Petra Van Kuik-Romeijn
Publikováno v:
Proceedings of the National Academy of Sciences USA, 106, 13915-20
Proceedings of the National Academy of Sciences USA, 106, 33, pp. 13915-20
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2009, 106 (33), pp.13915-13920. ⟨10.1073/pnas.0905780106⟩
Proceedings of the National Academy of Sciences USA, 106, 33, pp. 13915-20
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2009, 106 (33), pp.13915-13920. ⟨10.1073/pnas.0905780106⟩
Contains fulltext : 81075.pdf (Publisher’s version ) (Closed access) Myotonic dystrophy type 1 (DM1) is caused by toxicity of an expanded, noncoding (CUG)n tract in DM protein kinase (DMPK) transcripts. According to current evidence the long (CUG)n
Autor:
Derick G. Wansink, Walther J. A. A. van den Broek, Judith C.T. van Deutekom, Suzanne Bijl, Anchel González-Barriga, Ingeborg D.G. van Kessel, Bé Wieringa, Julia Kranzen, H.J.E. Croes, Baziel G.M. van Engelen, Susan A. M. Mulders
Publikováno v:
PLoS ONE
PLoS One, 10, 3
PLoS ONE, Vol 10, Iss 3, p e0121556 (2015)
PLoS One, 10
PLoS One, 10, 3
PLoS ONE, Vol 10, Iss 3, p e0121556 (2015)
PLoS One, 10
Contains fulltext : 154719.pdf (Publisher’s version ) (Open Access) Myotonic Dystrophy type 1 (DM1) is a multisystemic disease caused by toxic RNA from a DMPK gene carrying an expanded (CTG*CAG)n repeat. Promising strategies for treatment of DM1 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ff32d2a42b406e64a60b483f7f2219
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/154719
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/154719
Autor:
Derick G. Wansink, Walther J. A. A. van den Broek, Marcel R. Nelen, Bé Wieringa, Godfried W. van der Heijden
Publikováno v:
FEBS Letters, 580, 5208-14
FEBS Letters, 580, 22, pp. 5208-14
FEBS Letters, 580, 22, pp. 5208-14
Contains fulltext : 49344.pdf (Publisher’s version ) (Closed access) The mechanism of trinucleotide repeat expansion, an important cause of neuromuscular and neurodegenerative diseases, is poorly understood. We report here on the study of the role
Publikováno v:
BMC Molecular Biology, 8, 61-1-61
BMC Molecular Biology
BMC Molecular Biology, Vol 8, Iss 1, p 61 (2007)
BMC Molecular Biology, 8, pp. 61-1-61
BMC Molecular Biology
BMC Molecular Biology, Vol 8, Iss 1, p 61 (2007)
BMC Molecular Biology, 8, pp. 61-1-61
Contains fulltext : 52050.pdf ( ) (Open Access) BACKGROUND: Trinucleotide instability is a hallmark of degenerative neurological diseases like Huntington's disease, some forms of spinocerebellar ataxia and myotonic dystrophy type 1 (DM1). To investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2405161482683e83648abcd7068c3d7
http://hdl.handle.net/2066/52050
http://hdl.handle.net/2066/52050
Autor:
Carmen Perez-Terzic, Xiao Ke Liu, Derick G. Wansink, Walther J. A. A. van den Broek, Atta Behfar, Bé Wieringa, Garvan C. Kane, D. Fearghas O'Cochlain, Jeffrey A. Strommen, Andre Terzic, Santiago Reyes, Denice M. Hodgson
Publikováno v:
Human Molecular Genetics, 13, 2505-18
Human Molecular Genetics, 13, 20, pp. 2505-18
Human Molecular Genetics, 13, 20, pp. 2505-18
Contains fulltext : 59209.pdf (Publisher’s version ) (Closed access) Abnormal expression of human myotonic dystrophy protein kinase (hDMPK) gene products has been implicated in myotonic dystrophy type 1 (DM1), yet the impact of distress accumulatio
Autor:
Hein te Riele, Marga Coerwinkel, Derick G. Wansink, Bé Wieringa, Patricia J. T. A. Groenen, Walther J. A. A. van den Broek, Marcel R. Nelen
Publikováno v:
Human Molecular Genetics, 11, 2, pp. 191-8
Human Molecular Genetics, 11, 191-8
Human Molecular Genetics, 11, 191-8
Item does not contain fulltext The mechanism of expansion of the (CTG)n repeat in myotonic dystrophy (DM1) patients and the cause of its pathobiological effects are still largely unknown. Most likely, long repeats exert toxicity at the level of nucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78cd128872577af06349e9c0dbfd5f20
https://hdl.handle.net/2066/144566
https://hdl.handle.net/2066/144566